Press Releases from DelveInsight (513 total)
Triple Negative Breast Cancer Pipeline, Clinical Trials, FDA Approvals, Research …
DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Triple Negative Breast Cancer Companies and 80+ pipeline drugs in Triple…
Multiple Myeloma Pipeline, FDA Approvals, Clinical Trials Developments, and Comp …
DelveInsight's, "Multiple Myeloma Pipeline Insights" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It…
Postherpetic Neuralgia Market Size in 7MM is expected to witness a major change …
"The Postherpetic Neuralgia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple-…
Acute Pain Pipeline, Clinical and Non-Clinical Stages Products, and FDA Approval …
DelveInsight's, "Acute Pain Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Acute Pain pipeline landscape. It covers…
Cystic Fibrosis Pipeline, Clinical Trials Assessment, NDA Approvals, Emerging Dr …
DelveInsight's, "Cystic Fibrosis Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers…
Metastatic Pancreatic Cancer Pipeline and Clinical Trials Pipeline Analysis 2023 …
DelveInsight's, "Metastatic Pancreatic Cancer Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It…
Metastatic Renal Cell Carcinoma Marketed and Emerging Pipeline Drugs Assessment …
As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 50+ pipeline drugs in the Metastatic Renal Cell Carcinoma therapeutics…
CRISPR therapies Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Dr …
CRISPR therapies pipeline constitutes 25+ key companies continuously working towards developing 30+ CRISPR therapies treatment therapies, analyzes DelveInsight
CRISPR-Cas is an adaptive immune system existing in…
Glioma Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PM …
"Glioma Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Glioma Therapeutics Market.…
Vascular Access Devices Market is expected to Surge at a Significant CAGR of 6.6 …
Global Vascular Access Devices Market was valued at USD 4.59 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022…
Adult Growth Hormone Deficiency Market Size, Epidemiology, Pipeline, Therapies, …
Adult Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the pituitary gland in brain does not produce enough growth hormone. Most cases…
NSCLC Market Is Expected To Grow During The Forecast Period (2019-2032), DelveIn …
DelveInsight's "NSCLC Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the NSCLC, historical and forecasted epidemiology as well as the NSCLC…
Endoscopic Ultrasound Market Size, Drivers, Barriers, Landscape | Key Players- B …
DelveInsight's Endoscopic Ultrasound Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of Endoscopic Ultrasound and the historical and forecasted Endoscopic…
